Profile data is unavailable for this security.
About the company
Sectra AB is a Sweden-based technology company. It is operational through two business areas: Secure Communication Systems and Medical Systems. The Secure Communication Systems business area, which operates through the Company’s subsidiary Sectra Communications AB, delivers security solutions for customers who handle classified information, including government authorities, defense departments and critical functions of society throughout Europe. The Medical Systems business area, which operates through the subsidiary Sectra Imtec AB, offers information technology (IT) solutions, software licenses, service and upgrade agreements, online services, consultancy services and training courses to public and private healthcare providers. It has offices in 12 countries and operates through partners worldwide. As of April 30, 2012, the Company had six wholly owned direct subsidiaries, as well as 13 indirectly held wholly owned subsidiaries.
- Revenue in SEK (TTM)1.73bn
- Net income in SEK428.39m
- Incorporated1957
- Employees1.14k
- LocationSectra ABTeknikringen 20LINKOPING 583 30SwedenSWE
- Phone+46 13235200
- Fax+46 13212185
- Websitehttps://sectra.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ChemoMetec A/S | 612.00m | 219.17m | 9.20bn | 171.00 | 41.98 | 12.10 | 37.21 | 15.03 | 8.26 | 8.26 | 23.07 | 28.66 | 0.6982 | 0.8064 | 6.01 | 2,448,421.00 | 25.00 | 30.43 | 29.69 | 38.99 | 78.85 | 79.44 | 35.81 | 34.17 | 3.37 | -- | 0.0118 | 46.90 | 3.74 | 31.58 | 12.04 | 57.88 | 19.91 | -- |
| Arjo AB (publ) | 11.10bn | 518.00m | 10.35bn | 6.71k | 21.41 | 1.37 | 6.68 | 0.9323 | 1.90 | 1.90 | 40.76 | 29.72 | 0.6911 | 4.15 | 6.31 | 1,632,980.00 | 3.21 | 3.55 | 4.44 | 5.55 | 43.43 | 44.01 | 4.64 | 5.41 | 0.6913 | 4.14 | 0.4024 | 43.01 | 10.03 | 5.97 | 6.90 | 10.15 | -8.89 | 10.35 |
| Biotage AB | 1.98bn | 236.00m | 12.81bn | 669.00 | 53.18 | 3.29 | 31.78 | 6.47 | 3.01 | 3.01 | 25.57 | 48.61 | 0.5276 | 2.01 | 7.78 | 2,939,169.00 | 6.29 | 10.74 | 7.33 | 12.77 | 62.19 | 61.34 | 11.91 | 15.77 | 1.52 | 8.95 | 0.062 | 40.11 | 18.90 | 15.37 | -8.21 | 7.97 | 14.05 | 1.30 |
| Xvivo Perfusion AB | 642.95m | 100.43m | 12.85bn | 148.00 | 123.00 | 6.42 | 77.96 | 19.99 | 3.32 | 3.32 | 21.18 | 63.59 | 0.322 | 1.28 | 4.27 | 4,018,431.00 | 5.03 | 1.24 | 5.49 | 1.33 | 73.94 | 73.14 | 15.62 | 4.76 | 3.40 | -- | 0.0152 | 0.00 | 43.88 | 26.04 | 398.29 | 48.57 | 21.35 | -- |
| Embla Medical hf | 8.51bn | 602.26m | 19.22bn | 4.00k | 31.83 | 2.48 | 16.80 | 2.26 | 0.9263 | 0.9263 | 13.07 | 11.88 | 0.5582 | 2.20 | 6.60 | 1,396,049.00 | 3.96 | 4.06 | 4.68 | 4.76 | 61.41 | 62.47 | 7.09 | 6.91 | 1.07 | 5.81 | 0.4325 | 3.99 | 9.33 | 5.09 | 37.34 | -6.05 | 6.50 | -- |
| Vitrolife AB | 3.50bn | -3.84bn | 22.63bn | 1.13k | -- | 1.71 | -- | 6.47 | -28.33 | -28.33 | 25.84 | 97.73 | 0.1859 | 3.76 | 6.54 | 3,242,818.00 | -20.38 | -4.57 | -21.03 | -4.78 | 56.39 | 58.38 | -109.60 | -21.89 | 2.98 | -30.31 | 0.1353 | -- | 8.60 | 24.99 | -1,077.41 | -- | -7.95 | 3.30 |
| Elekta AB (publ) | 18.12bn | 1.30bn | 24.14bn | 4.58k | 19.29 | 2.32 | 9.89 | 1.33 | 3.40 | 3.40 | 47.32 | 28.20 | 0.5939 | 3.58 | 3.01 | -- | 4.27 | 4.19 | 7.60 | 7.51 | 37.55 | 39.03 | 7.19 | 7.37 | 0.7644 | 3.85 | 0.4021 | 71.71 | 7.41 | 5.98 | 38.07 | 1.68 | 20.06 | 5.92 |
| Sectra AB | 1.73bn | 428.39m | 43.48bn | 1.14k | 108.03 | 29.48 | 81.65 | 25.20 | 2.22 | 2.22 | 8.95 | 8.15 | 0.5801 | -- | 3.60 | 1,513,253.00 | 14.41 | 15.75 | 28.61 | 29.52 | 47.24 | 64.95 | 24.83 | 19.59 | -- | -- | 0.0199 | -- | 26.84 | 4.06 | 14.25 | 16.58 | 48.37 | -- |
| Getinge AB | 32.20bn | 2.28bn | 45.93bn | 11.86k | 21.55 | 1.52 | 10.94 | 1.43 | 8.39 | 8.39 | 118.22 | 118.80 | 0.6001 | 2.53 | 6.79 | 2,742,908.00 | 4.29 | 5.31 | 5.56 | 6.98 | 45.37 | 47.83 | 7.15 | 8.69 | 0.7569 | 8.93 | 0.2035 | 37.87 | 12.49 | 5.66 | -3.17 | -- | -0.3944 | 34.49 |
| Ambu A/S | 7.73bn | 559.35m | 48.87bn | 4.75k | 98.78 | 6.48 | 43.62 | 6.32 | 1.38 | 1.38 | 19.09 | 21.05 | 0.7251 | 2.13 | 7.17 | 1,099,437.00 | 5.24 | 3.81 | 5.99 | 4.62 | 57.91 | 59.37 | 7.23 | 5.43 | 1.49 | 16.93 | 0.101 | 22.89 | 7.45 | 12.88 | 80.65 | -13.00 | 6.67 | -- |
| Demant A/S | 34.21bn | 3.89bn | 100.42bn | 21.62k | 26.06 | 7.10 | -- | 2.94 | 11.44 | 8.05 | 100.58 | 41.97 | 0.7431 | 2.05 | 5.88 | 1,037,923.00 | 8.46 | 8.27 | 12.20 | 13.23 | 73.72 | 74.14 | 11.38 | 11.34 | 0.9529 | 5.98 | 0.6075 | 0.00 | 13.89 | 10.00 | 12.23 | 6.96 | 8.80 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management ABas of 29 Apr 2024 | 19.64m | 10.85% |
| SEB Investment Management ABas of 31 May 2024 | 14.89m | 8.23% |
| Fj�rde AP-fondenas of 31 Dec 2023 | 9.52m | 5.26% |
| AMF Fonder ABas of 30 Apr 2023 | 8.04m | 4.44% |
| The Vanguard Group, Inc.as of 06 Jun 2024 | 5.52m | 3.05% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 3.71m | 2.05% |
| Swedbank Robur Fonder ABas of 31 May 2024 | 3.41m | 1.89% |
| Cliens Kapitalf�rvaltning ABas of 31 Mar 2024 | 3.39m | 1.87% |
| Brown Capital Management LLCas of 31 Mar 2024 | 3.17m | 1.75% |
| Lannebo Fonder ABas of 31 Dec 2023 | 2.16m | 1.20% |
